Skip to content

Placebo Effect

Active
Private limited companyfounded 2016active for 10 yearsVieux Chemin de Louvain,H.-M. 53, 1320 Beauvechain, BelgiumKBO/BCE: BE 0659.838.837

Acts, filings and financial milestones

Deadline for the 2026 accounts: 31-07-2027
2026
16-07
NBB filing Annual accounts 2025 filedNBB
abbreviated format · 15 days before the deadline
16-07
NBB filing Annual accounts 2024 filedNBB
abbreviated format · 350 days late
08-05
Gazette deed Change of role: MEULEMANS, Anne Françoise Marie Pauline Willy, from manager to director
Capital conversion · Reserve release · Amendment of the articles11 points ▸
  • General meeting, 04-05-2026
  • Other provision, “société à responsabilité limitée” (deed in French)
  • Capital conversion, “compte de capitaux propres statutairement indisponible” (deed in French)
  • Capital conversion, “compte de capitaux propres apports non appelés” (deed in French)
  • Reserve release, “suppression, fonds disponibles pour distribution” (deed in French)
  • Amendment of the articles
  • Capital
  • Director resignation, MEULEMANS, Anne Françoise Marie Pauline Willy (manager)
  • Director appointment, MEULEMANS, Anne Françoise Marie Pauline Willy (director (not named in the articles))
  • Other provision, “décharge gérant démissionnaire pour exécution mandat, à décider” (deed in French)
  • Registered office clause, “1320 Beauvechain (Hamme-Mille), Vieux Chemin de Louvain 53” (deed in French)

Open the act in the Belgian Official Gazette

2024
31-12
Financial Liquidity more than doubledcurrent ratio 5.02
The current ratio rises from 1.87 to 5.02. Short-term debt falls from €46,203 to €20,394.
31-12
Financial Equity above €100,000equity €106,107 ▲55.9%
After 2 profitable years in a row, equity reaches €106,107.
30-08
NBB filing Annual accounts 2023 filedPDF
full format · 30 days late
2023
31-12
Financial Back to profitnet €44,946
The net result is €44,946, after one loss-making year.
06-09
NBB filing Annual accounts 2022 filedPDF
full format · 37 days late
30-01
NBB filing Annual accounts 2021 filedPDF
full format · 183 days late
2022
31-12
Financial Weakest financial yearnet -€8,379
The net result drops to -€8,379, the lowest from 2018 to 2025. It recovers the following year.
2021
31-12
Financial Liquidity more than doubledcurrent ratio 10.38
The current ratio rises from 4.23 to 10.38. Short-term debt falls from €37,804 to €13,339.
06-09
NBB filing Annual accounts 2020 filedPDF
micro format · 37 days late
Show earlier events
2020
31-12
Financial Highest result from 2018 to 2025net €48,350 ▲212%
The operating result of €62,982 and the net result of €48,350 are both a record.
31-12
Financial Equity above €100,000equity €122,040 ▲152%
With a profit in every financial year since 2018, equity grows to €122,040.
2019
10-10
NBB filing Annual accounts 2018 filedPDF
micro format · 71 days late
2018
27-09
NBB filing Annual accounts 2017 filedPDF
micro format · 58 days late
2016
25-07
Gazette deed IncorporationPDF
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.

Sources:Publications in the Belgian Official GazetteFilings with the National Bank

History

Placebo Effect was incorporated on 21 July 2016.1 Total assets rose from €68,135 in 2018 to €138,405 in 2025.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2018 and 2025

Next steps